Inhibition of lipid peroxidation in low-density lipoprotein by the flavonoid myrigalone B and ascorbic acid
- 28 June 1996
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 51 (12) , 1719-1725
- https://doi.org/10.1016/0006-2952(96)00107-4
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Antioxidant Vitamins and Coronary Heart DiseaseNew England Journal of Medicine, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wineThe Lancet, 1993
- The role of lipid peroxidation and antioxidants in oxidative modification of LDLFree Radical Biology & Medicine, 1992
- The inhibition of the oxidation of low density lipoprotein by (+)-Catechin, a naturally occurring flavonoidBiochemical Pharmacology, 1992
- Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines☆Free Radical Biology & Medicine, 1992
- The antioxidant butylated hydroxytoluene protects against atherosclerosis.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophagesBiochemical Pharmacology, 1990
- α-tocopherol consumption during low-density-lipoprotein oxidationBiochemical Journal, 1990
- Probucol inhibits oxidative modification of low density lipoprotein.Journal of Clinical Investigation, 1986